EPCAM and hepatocellular carcinoma: All-trans retinoic acid treatment reduced sorafenib-induced EpCAM+ cells and clonal growth via the inhibition of Akt phosphorylation in Huh7 HCC cells, thereby eradicating sorafenib resistance in culture and in the PDX model [140].